# Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

> **NCT03887520** · NA · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 49001 (actual)

## Conditions studied

- Cardiovascular Disease and Lipoprotein(a)

## Interventions

- **DIAGNOSTIC_TEST:** Blood draw for Lp(a)

## Key facts

- **NCT ID:** NCT03887520
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-27
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 49001 (ACTUAL)
- **Last updated:** 2022-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03887520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03887520, "Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03887520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*